A curated list of open funding calls and other support for researchers, non-profit organizations and commercial organizations, specifically for COVID-19 and coronavirus-related research. Updated daily.
On 19 May EFPIA, the European Federation of Pharmaceutical Industries and Associations, organised “Clinical Trials at the time of COVID-19 – and beyond”, as part of the series of our virtual events. On the occasion of International Clinical Trials Day on 20 May, this event wished to explore the takeaways that COVID-19 teaches us on how to optimise […]
Scientists, physicians, funders, and policy makers, including the Bill & Melinda Gates Foundation, the Institute of Tropical Medicine and the Pasteur Institute, have come together in an international coalition called the COVID-19 Clinical Research Coalition, to help counter the COVID-19 pandemic. The coalition aims to accelerate desperately needed COVID-19 research in those areas where the […]
To illuminate some of the recent developments pursued by leading scientists during the pandemic, the IUIS collaborated with Frontiers and launched a series of weekly scientific webinars to accelerate the development of novel diagnostics, therapeutics and vaccines. Speakers shared their insights and latest research results on Covid-19-related topics, welcoming an audience that featured more than […]
This report from FasterCures identifies practices that have emerged from the COVID-19 crisis that should be preserved and enhanced. Its focus centers on five areas: (1) research collaboration; (2) acceleration of product development; (3) clinical trial design and execution; (4) collection and use of real-world data and evidence; and (5) racial and ethnic disparities in health care […]
On December 11th, the European Medicines Agency (EMA) hosted a public stakeholder meeting on development and authorisation of safe and effective COVID-19 vaccines in the EU. Watch the recording by clicking the button below.
Researchers and ethicists are usually hesitant to deliberately expose volunteers to a virus, but thousands of people have signed up to help fast-track clinical trials. This articles discusses why human challenge trials are back on the table, the ethical questions that they raise and the challenges ahead.
The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential to ensure the resilience of clinical cancer research and optimize patient-centered care. […]
COVID-19 has raised a plethora of ethical issues – from prevention and containment, to cure and management. Join leading experts to discuss these issues in a Bioethics Interest Group (BIG) webinar series focused on COVID-19 ethical considerations. Hosted by the Office of Research Excellence and moderated by Adnan Hyder, Senior Associate Dean for Research, these […]
Vaccines, medicines, coronavirus tests – in a world awash with rumour and pseudoscience, we look at how experts figure out what really works in the fight against COVID-19 We are facing two pandemics: a new virus circulating globally, and a worldwide outbreak of pseudoscience and ‘fake news’. Even if you have not yet personally encountered […]
